Literature DB >> 21874350

Insights into NK cell biology from human genetics and disease associations.

Stephanie M Wood1, Hans-Gustaf Ljunggren, Yenan T Bryceson.   

Abstract

Rare human primary immunodeficiency disorders with extreme susceptibility to infections in infancy have provided important insights into immune function. Increasingly, however, primary immunodeficiencies are also recognized as a cause of other more common, often discrete, infectious susceptibilities. In a wider context, loss-of-function mutations in immune genes may also cause disorders of immune regulation and predispose to cancer. Here, we review the associations between human diseases and mutations in genetic elements affecting natural killer (NK) cell development and function. Although many such genetic aberrations significantly reduce NK cell numbers or severely impair NK cell responses, inferences regarding the role of NK cells in disease are confounded by the fact that most mutations also affect the development or function of other cell types. Still, data suggest an important role for NK cells in diseases ranging from classical immunodeficiency syndromes with susceptibility to viruses and other intracellular pathogens to cancer, autoimmunity, and hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874350     DOI: 10.1007/s00018-011-0799-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  157 in total

Review 1.  Perforin: structure, function, and role in human immunopathology.

Authors:  Ilia Voskoboinik; Michelle A Dunstone; Katherine Baran; James C Whisstock; Joseph A Trapani
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Fatal varicella associated with selective natural killer cell deficiency.

Authors:  Amos Etzioni; Celine Eidenschenk; Rina Katz; Rafeal Beck; Jean Laurent Casanova; Shimon Pollack
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

Review 3.  SNAREs--engines for membrane fusion.

Authors:  Reinhard Jahn; Richard H Scheller
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08-16       Impact factor: 94.444

4.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Defective neutrophil and lymphocyte function in leucocyte adhesion deficiency.

Authors:  Y L Lau; L C Low; B M Jones; J W Lawton
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.

Authors:  I Monleón; M J Martínez-Lorenzo; L Monteagudo; P Lasierra; M Taulés; M Iturralde; A Piñeiro; L Larrad; M A Alava; J Naval; A Anel
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

7.  Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.

Authors:  Vivian Hwa; Brian Little; Pelin Adiyaman; Eric M Kofoed; Katherine L Pratt; Gonul Ocal; Merih Berberoglu; Ron G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  2005-04-12       Impact factor: 5.958

8.  Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I.

Authors:  M J Smyth; M J McGuire; K Y Thia
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

9.  Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.

Authors:  Yenan T Bryceson; Eva Rudd; Chengyun Zheng; Josefine Edner; Daoxin Ma; Stephanie M Wood; Anne Grete Bechensteen; Jaap J Boelens; Tiraje Celkan; Roula A Farah; Kjell Hultenby; Jacek Winiarski; Paul A Roche; Magnus Nordenskjöld; Jan-Inge Henter; Eric O Long; Hans-Gustaf Ljunggren
Journal:  Blood       Date:  2007-05-24       Impact factor: 22.113

10.  Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.

Authors:  Udo zur Stadt; Jan Rohr; Wenke Seifert; Florian Koch; Samantha Grieve; Julia Pagel; Julia Strauss; Brigitte Kasper; Gudrun Nürnberg; Christian Becker; Andrea Maul-Pavicic; Karin Beutel; Gritta Janka; Gillian Griffiths; Stephan Ehl; Hans Christian Hennies
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

View more
  18 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

2.  Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells.

Authors:  Aleksandra Gil-Krzewska; Stephanie M Wood; Yousuke Murakami; Victoria Nguyen; Samuel C C Chiang; Andrew R Cullinane; Giovanna Peruzzi; William A Gahl; John E Coligan; Wendy J Introne; Yenan T Bryceson; Konrad Krzewski
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

3.  HkRP3 is a microtubule-binding protein regulating lytic granule clustering and NK cell killing.

Authors:  Hyoungjun Ham; Walter Huynh; Renee A Schoon; Ronald D Vale; Daniel D Billadeau
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

Review 4.  Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.

Authors:  May Daher; Katayoun Rezvani
Journal:  Curr Opin Immunol       Date:  2018-03-30       Impact factor: 7.486

Review 5.  Natural killer cells and antifungal host response.

Authors:  Stanislaw Schmidt; Stefanie-Yvonne Zimmermann; Lars Tramsen; Ulrike Koehl; Thomas Lehrnbecher
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

6.  Human NK cell lytic granules and regulation of their exocytosis.

Authors:  Konrad Krzewski; John E Coligan
Journal:  Front Immunol       Date:  2012-11-09       Impact factor: 7.561

Review 7.  On the role of natural killer cells in neurodegenerative diseases.

Authors:  Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2013-02-19       Impact factor: 4.546

Review 8.  "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy.

Authors:  Senthamil R Selvan; John P Dowling
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

Review 9.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31

10.  HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing.

Authors:  Moran Elboim; Inna Grodzovski; Esther Djian; Dana G Wolf; Ofer Mandelboim
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.